Naujausios naujienos ir straipsniai apie genetinius tyrimus
May 23, 2026
Researchers have identified molecular glues that can protect insulin-producing cells from damage related to diabetes. These findings could potentially lead to new therapeutic strategies for managing and treating this condition.
May 23, 2026
The Mount Sinai Hospital / Mount Sinai School of Medicine. "Researchers identify molecular glues that protect insulin-producing cells from damage related to diabetes." ScienceDaily. ScienceDaily, 4 Ma...
May 23, 2026
Researchers at the University of Kent have identified a skincare compound that exhibits potent antibacterial activity against drug-resistant bacteria. This finding has potential implications for the development of new treatments for infections caused by multidrug-resistant pathogens.
May 23, 2026
University of Kent. "Scientists discover skincare compound that kills drug-resistant bacteria." ScienceDaily. ScienceDaily, 21 April 2026. <www.sciencedaily.com/releases/2026/04/260420014738.htm>...
May 23, 2026
Researchers have developed a gene-based blood test that may detect early signs of melanoma recurrence. This non-invasive test could potentially improve patient outcomes by identifying cancer return at an earlier stage.
May 23, 2026
Researchers have developed a gene-based blood test that may help detect early signs of melanoma recurrence. This non-invasive test has the potential to improve treatment outcomes for patients with skin cancer.
May 23, 2026
University of Kent. "Scientists discover skincare compound that kills drug-resistant bacteria." ScienceDaily. ScienceDaily, 21 April 2026. <www.sciencedaily.com/releases/2026/04/260420014738.htm>...
May 23, 2026
Researchers have made significant breakthroughs in enzyme engineering, paving the way for novel therapies for diseases such as Parkinson's disease and certain types of cancer. This innovative approach has the potential to target protein-based diseases that were previously resistant to treatment.
May 23, 2026
Researchers at the Scripps Research Institute have made significant advancements in enzyme engineering, potentially paving the way for novel treatments for Parkinson's disease, cancer, and other protein-related disorders. This breakthrough holds promise for developing more effective therapies for previously untreatable conditions.
